Back to search results

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Abroad (travel likely)Recruiting

Conditions

ICAD - Intracranial Atherosclerotic Disease · ICAS - Intracranial Atherosclerosis · Drug-eluting Stent · Stroke · Drug Eluting Stents (DES) · Medical Treatment

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zhongrong Miao, MD) · 13601243293@163.com · 13601243293
Beijing Daxing District People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jinglin Yuan) · yuanjl3344@126.com · 86+13426252069
Contact: Principal Investigator (Jinglin Yuan)
Hejian People's Hospital, Cangzhou, Hebei, China
Contact: Study coordinator (Dong Sun) · 18632768855@163.com · 18632768855
Contact: Principal Investigator (Dong Sun)
North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China
Contact: Study coordinator (Chengjing Xue) · 506944567@qq.com · 86+15130567788
Contact: Principal Investigator (Chengjing Xue)
Xingtai City Third Hospital, Xingtai, Hebei, China
Contact: Study coordinator (Yingyi Li) · yingyilixt@163.com · 86+13932981963
Contact: Principal Investigator (Yingyi Li)
General Hospital of The Yangtze River Shipping, Wuhan, Hubei, China
Contact: Study coordinator (Wanming Wang) · 1048026357@qq.com · 86+18907185598
Contact: Principal Investigator (Wanming Wang)
Baotou Central Hospital, Baotou, Inner Mongolia, China
Contact: Study coordinator (Changchun Jiang) · 13347180510@163.com · 86+13347180510
Contact: Principal Investigator (Changchun Jiang)
Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia, China
Contact: Study coordinator (Rile Wu) · wurile@hotmail.com · 86+15326000666
Contact: Principal Investigator (Rile Wu)
Tongliao City Hospital, Tongliao, Inner Mongolia, China
Contact: Study coordinator (Peng Xu) · doujiaogaibei@163.com · 18347588080
Contact: Principal Investigator (Peng Xu)
Wuhai People's Hospital, Wuhai, Inner Mongolia, China
Contact: Study coordinator (Hu Shen) · shenhu168@yeah.net · 86+13848309996
Contact: Principal Investigator (Hu Shen)
The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Guibing Ding) · yuxiazaizai@126.com · 86+1377666937
Contact: Principal Investigator (Guibing Ding)
The Second Norman Bethune Hospital of JilinUniversity,, Changchun, Jilin, China
Contact: Study coordinator (Long Yan) · yanlong101@jlu.edu.cn · 86+15543686866
Contact: Principal Investigator (Long Yan)
General Hospital of Benxi Iron and Steel Co, Benxi, Liaoning, China
Contact: Study coordinator (Qian Wang) · bgzywq5257@163.com · 86+13941431375
Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China
Contact: Study coordinator (Dong Kuai) · kuaidong12345@163.com · 86+13835172104
Contact: Principal Investigator (Dong Kuai)
Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China
Contact: Study coordinator (Yaxuan Sun) · rvlm@163.com · 86+13834578394
Contact: Principal Investigator (Yaxuan Sun)
The First Affiliated Hospital of College of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Ziqi Xu) · zyxuziqi@zju.edu.cn · 86+13858192341
Contact: Principal Investigator (Ziqi Xu)
Lishui People's Hospital, Lishui, Zhejiang, China
Contact: Study coordinator (Lin Xiang) · 61365310@qq.com · 86+18957091688
Contact: Principal Investigator (Lin Xiang)
Beilun People's Hospital of Ningbo City, Ningbo, Zhejiang, China
Contact: Study coordinator (Xing Fang) · 58189633@qq.com · 86+13567432657
Contact: Principal Investigator (Xing Fang)

Study leads

Yongjun Wang, MD
Principal Investigator
Beijing Tiantan Hospital
Zhongrong Miao, MD
Principal Investigator
Beijing Tiantan Hospital

View source on ClinicalTrials.gov